In pro-B acute lymphoblastic leukemia, and brain, esophageal, liver, testis, ovarian, and gastric cancers, CD133 is overexpressed while in other cancer types, including kidney cancer, CD133 is down-regulated [69]. Here, PROM1 is linked to cancer.